S. 5059 · Senate bill · 119th Congress

A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.

Sponsored by Sen. Ashley Moody, Florida with 3 co-sponsors

Introduced Jul 21, 2026

Referred to the Health, Education, Labor, and Pensions Committee

Latest action Jul 21, 2026

Show 1 more cosponsor

No summary yet. The Congressional Research Service usually summarizes a bill within weeks of a new version.

Read the bill

About 28 words

Contents

Section 351(k)(5) of the Public Health Service Act (42 U.S.C. 262(k)(5)) is amended—

(1) by striking subparagraph (B); and

(2) by redesignating subparagraph (C) as subparagraph (B).

Official text, Introduced in Senate (Jul 21, 2026), from the Government Publishing Office via Congress.gov. Printed version (PDF) · All versions on Congress.gov